title: Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China.
authors.affiliation: Department of Ophthalmology, Peking University People's Hospital; Key Laboratory of Vision Loss and Restoration, Ministry of Education; and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China; Department of Ophthalmology, People's Liberation Army (PLA) Rocket Force General Hospital, Beijing, China.
authors.forename: Jing
authors.initials: J
authors.lastname: Feng
authors.affiliation: Department of Ophthalmology, Children's Hospital of Nanjing Medical University, Nanjing, China.
authors.forename: Jing
authors.initials: J
authors.lastname: Qian
authors.affiliation: Department of Ophthalmology, Peking University People's Hospital; Key Laboratory of Vision Loss and Restoration, Ministry of Education; and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China. Electronic address: dryrjiang@sina.com.
authors.forename: Yanrong
authors.initials: Y
authors.lastname: Jiang
authors.affiliation: Department of Ophthalmology, Peking University People's Hospital; Key Laboratory of Vision Loss and Restoration, Ministry of Education; and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China.
authors.forename: Mingwei
authors.initials: M
authors.lastname: Zhao
authors.affiliation: Department of Ophthalmology, Peking University People's Hospital; Key Laboratory of Vision Loss and Restoration, Ministry of Education; and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China.
authors.forename: Jianhong
authors.initials: J
authors.lastname: Liang
authors.affiliation: Department of Ophthalmology, Peking University People's Hospital; Key Laboratory of Vision Loss and Restoration, Ministry of Education; and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Yin
authors.affiliation: Department of Ophthalmology, Peking University People's Hospital; Key Laboratory of Vision Loss and Restoration, Ministry of Education; and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China; Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China.
authors.forename: Yi
authors.initials: Y
authors.lastname: Chen
authors.affiliation: Department of Ophthalmology, Peking University People's Hospital; Key Laboratory of Vision Loss and Restoration, Ministry of Education; and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China.
authors.forename: Wenzhen
authors.initials: W
authors.lastname: Yu
authors.affiliation: Department of Ophthalmology, Peking University People's Hospital; Key Laboratory of Vision Loss and Restoration, Ministry of Education; and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China. Electronic address: drlxx@sina.cn.
authors.forename: Xiaoxin
authors.initials: X
authors.lastname: Li
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D002681:China; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D058449:Intravitreal Injections; D008297:Male; D000069579:Ranibizumab / Q000008:administration & dosage*; D012008:Recurrence; D012178:Retinopathy of Prematurity / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000069579:Ranibizumab